Using intragastic balloon procedure for surgical risks reduction in patients with morbid obesity

Abstract

Introduction. According to the latest WHO data, in Ukraine we have 22% of men and 25,7% of women with obesity. Morbidly obese patients have high surgical risks that are associated with mortality. Objectives.The aim of this study is to estimate surgical risks in patients with morbid obesity who underwent intragastic balloon procedure as a preparation for bariatric surgery. Methods. The study included 65 patients with morbid obesity who underwent intragastic balloon (IGB) Orbera procedure for 6 months. Surgical risks were estimated according to ASA Physical Status Classification System (2014). Results. After IGB procedure patients showed median percent excess weight loss (% EWL) of 21,80 (18,60- 26,50). Median BMI reduction from 68,08 (63,40-73,83) kg/m2 to 56,65 (51,96-65,23) kg/m2 (p < 0,001). Surgical risks were reduced from ASA PS III 47 (72,31%) and ASA PS IV 18 (27.7%) to ASA PS III 9 (13, 9%) and ASA PS II 56 (86,2%). 60 (92,3 %) patients underwent bariatric surgery (laparoscopic gastric bypass - 83,3%, laparoscopic adjustable gastric banding - 15%, laparoscopic sleeve gastrectomy - 1,7%). There was no mortality. In 2 (3,3%) patients we had complications associated with wound infection. Conclusion. Intragastic balloon procedure is an effective for surgical risk reducing of bariatric surgery in patients with morbid obesity.